A membrane TNF-α/TNFR ratio correlates to mods score and mortality

Shock

Volumn 6, Issue 6, 1996, Pages 389-396

  Pellegrini, Joan D ^a   Puyana, Juan Carlos ^a   Lapchak, Peter H ^a   Kodys, Karen ^a   Miller Graziano, Carol L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD; CELL MEMBRANE; CLINICAL TRIAL; HOSPITALIZATION; HUMAN; INJURY; METABOLISM; MIDDLE AGED; MONOCYTE; MORTALITY; MULTIPLE ORGAN FAILURE; SECRETION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CELL MEMBRANE; HUMANS; MIDDLE AGED; MONOCYTES; MULTIPLE ORGAN FAILURE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS AND INJURIES;

EID: 0030331273     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199612000-00001     Document Type: Article

References (38)

1. Fisher CJ, Jr, Opal SM, Dhainaut J-F, et al: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit. Care Med. 21:318-327, 1993.
2. Spinas GA, Keller U, Brockhaus M: Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J. Clin. Invest. 90:533-536, 1992.
3. Demling R, Saldinger P, Lalonde C, Knox J: Multiple-organ dysfunction in the surgical patient: Pathophysiology, prevention, and treatment. Curr. Probl. Surg. 30:347-415, 1993.
4. Fabian TC, Croce MA, Fabian MJ, Trenthem LL, Yockey JM, Boscarino R, Proctor KG: Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: Experimental results and clinical correlation. Surgery 118:63-72, 1995.
5. Rabinovici R, John R, Esser KM, Vernick J, Feuerstein G: Serum tumor necrosis factor-alpha profile in trauma patients. J. Trauma 35:698-702, 1993.
6. Cavaillon J-M, Munoz C, Fitting C, Misset B, Carlet J: Circulating cytokines: The tip of the iceberg? Circ. Shock 38:145-152, 1992.
7. Fink MP: Another negative clinical trial of a new agent for the treatment of sepsis: Rethinking the process of developing adjuvant treatments for serious infections. Crit. Care Med. 23:989-991, 1995.
8. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 23:1638-1652, 1995.
9. Nakabo Y, Harakawa N, Yamamoto K, Okuma M, Uno K, Sasada M: Leukemic cell lysis by activated human macrophages: Significance of membrane-associated tumor necrosis factor. Jpn. J. Cancer Res. 84:1174-1180, 1993.
10. Agostini C, Zambello R, Trentin L, et al: Expression of TNF Receptors by T Cells and Membrane TNF-α by Alveolar Macrophages Suggests a Role for TNF-α in Regulation of the Local Immune Responses in the Lung of HIV-1 Infected Patients. J. Immunol. 154:2928-2938, 1995.
11. Nu A, Sone S, Orino E, Ogura T: Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-α in human alveolar macrophages. J. Leukocyte Biol. 53:29-36, 1993.
12. Grell M, Douni E, Wajant H, et al: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802, 1995.
13. See RH, Chow AW: Role of the adhesion molecule lymphocyte function associated antigen 1 in toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1β secretion by human monocytes. Infect. Immun. 60:4957-4960, 1992.
14. Ayala A, Perrin MM, Wang P, Ertel W, Chaudry IH: Hemorrhage induces enhanced kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity: Involvement of cell-associated tumor necrosis factor and reactive nitrogen. J. Immunol. 147:4147-4154, 1991.
15. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H: Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J. Immunol. 150:4346-4353, 1993.
16. Kowalczyk D, Mytar B, Jasinski M, Pryjma J, Zembala M: Modulation of monocyte antigen-presenting capacity by tumour necrosis factor-alpha (TNF): Opposing effects of exogeneous TNF before and after an antigen pulse and the role of TNF gene activation in monocytes. Immunol. Lett. 44:51-57, 1995.
17. Ertel W, Keel M, Bonaccio M, Steckholzer U, Gallati H, Kenney JS, Trentz O: Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J. Trauma 39:879-887, 1995.
18. Calvano SE, Van der Poll T, Coyle SM, Barie PS, Moldawer LL, Lowry SF: Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. Arch. Surg. 131:434-437, 1996.
19. Cinat M, Waxman K, Vaziri ND, et al: Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J. Trauma 39:112-118, 1995.
20. Szabo G, Miller-Graziano CL, Wu J-Y, Takayama T, Kodys K: Differential tumor necrosis factor production by human monocyte subsets. J. Leuk. Biol. 47:206-216, 1990.
21. Miller-Graziano CL, Szabo G, Kodys K, Griffey K: Aberrations in posttrauma monocyte subpopulation: Role in septic shock syndrome. J. Trauma 30:S86-S97, 1990.
22. Durieux J-J, Vita N, Popescu O, et al: The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes. Eur. J. Immunol. 24:2006-2012, 1994.
23. Hsi ED, Remick DG: Methods in laboratory investigation: Rapid determination of cell-associated tumor necrosis factor production by flow cytometry. Lab. Invest. 68:740-745, 1993.
24. Calandra T, Baumgartner J-D, Grau GE, et al: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J. Infect. Dis. 161:982-987, 1990.
25. Marano MA, Fong Y, Moldawer LL, et al: Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol. Obstet. 170:32-38, 1990.
26. Rixen D, Siegel JH, Abu-Salih A, Bertolini M, Panagakos F, Espina N: Physiologic state severity classification as an indicator of posttrauma cytokine response. Shock 4:27-38, 1995.
27. Roumen RMH, Hendriks T, Van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg. 218:769-776, 1993.
28. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, Murray JF: Plasma tumor necrosis factor in patients with septic shock: Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141:94-97, 1990.
29. Svoboda P, Kantorova I, Ochmann J: Dynamics of interluekin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J. Trauma 36:336-340, 1994.
30. Van der Poll T, Lowry SF: Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3:1-12, 1995.
31. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 103:565-575, 1993.
32. 2 production by trauma patients' monocytes. Arch. Surg. 125:29-35, 1990.
33. Munoz C, Misset B, Fitting C, Bleriot J-P, Cavaillon J-C, Cavaillon J-M: Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Imm. 21:2177-2184, 1991.
34. Winzen R, Wallach D, Engelmann H, et al: Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells. J. Immunol. 148:3454-3460, 1992.
35. Tartaglia LA, Pennica D, Goeddel DV: Ligand Passing: The 75-kDa Tumor Necrosis Factor (TNF) Receptor Recruits TNF for Signaling by the 55-kDa TNF Receptor. J. Biol. Chem. 268:18542-18548, 1993.
36. Miller-Graziano CL, Kodys K, Gonzalez F, Fudem GM: Continued tumor necrosis factor receptor expression by trauma patients' monocytes (Mφ) despite TNFα secretion. Shock 1:317-324, 1994.
37. Guo TL, Mudzinski SP, Lawrence DA: The heavy metal lead modulates the expression of both TNF-α and TNF-α receptors in lipopolysaccharide-activated human peripheral blood mononuclear cells. J. Leuk. Biol. 59: 932-939, 1996.
38. Remick DG: Treatment of septic shock by inhibiting TNF. Shock 2:21-22, 1994.